Russell Investments Group
STML

Russell Investments Group’s Stemline Therapeutics, Inc. STML Stock Holding History

Russell Investments Group’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-51,016
Closed -$245K – 3254
2020
Q1 		$245K Buy
+51,016
New +$331K ﹤0.01% 2474

Russell Investments Group's STML Position: Q2 2020 in Review

Russell Investments Group sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 51,016 shares — an estimated $245K sold.

Russell Investments Group first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $245K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Russell Investments Group reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Russell Investments Group sold 51,016 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $245K.
  • Russell Investments Group first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Russell Investments Group's Stemline Therapeutics, Inc. position peaked at $245K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Russell Investments Group's 13F filing for Q2 2020, filed 5 Aug 2020.